By Steve Scherer ( June 4, 2026, 16:39 GMT | Insight) -- Companies across the music, technology and life sciences sectors announced over the past two weeks licensing transactions involving AI, standard essential patents, drug candidates and rare earth technologies. The purchase of an IP licensing firm was also announced.Generative AI, standard essential patents and life sciences drove recent licensing activities. Highlights included Spotify and Universal Music Group’s agreement covering AI-generated works, the continued growth of SEP licensing programs operated by Sisvel and Avanci, Fortress Investment Group’s acquisition of patent licensing firm IPValue, and multibillion dollar pharmaceutical licensing deals....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.